☆ 4.4 Letter

Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia

HAEMATOLOGICA (2014)

Get Full Text
Add to Collection

Journal

HAEMATOLOGICA
Volume 99, Issue 10, Pages E179-E181

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2014.104760

Keywords

MDS; TP53 mutations; p53 expression; azacitidine

Categories

Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.